We provide vaccination services including and not limited to Gardasil9 and Zostavax.
Gardasil 9 was officially launched in April 2016 offering an enhanced version of the vaccine to protect against 9 strains of HPV.
The new Gardasil 9 covers the following HPV types, 6, 11, 16, 18, 31, 33, 45, 52 and 58.
These 9 HPV types also cause premalignant lesions and cancers affecting the cervix, vulva and anus, and genital warts (Condyloma acuminata).
Gardasil 9 has the potential to prevent approximately 80-90% of cervical, vulvar, vaginal and anal cancers while Gardasil 4 has 50-75%.
Zostavix is a live attenuated virus vaccine indicated for prevention of herpes zoster (shingles) in individuals 50 years of age and older.